Global Choroideremia Treatment Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Choroideremia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Choroideremia Treatment.
The Choroideremia Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Choroideremia Treatment market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Choroideremia Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Choroideremia Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Choroideremia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Choroideremia Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Choroideremia Treatment market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Choroideremia Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
- Novartis AG
- Spark Therapeutics
- Bluebird Bio Inc.
- Biogen
- Copernicus Therapeutics, Inc.
- 4D Molecular Therapeutics
- Wize Pharma Inc.
- Retina Implant AG
- Hoffmann-La Roche Ltd
- Pixium Vision
- Merck
- Teva
- Oral
- Intravenous
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Choroideremia Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Choroideremia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 CHOROIDEREMIA TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of Choroideremia Treatment
1.2 Choroideremia Treatment Segment by Type
1.2.1 Global Choroideremia Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Oral
1.2.3 Intravenous
1.3 Choroideremia Treatment Segment by Application
1.3.1 Global Choroideremia Treatment Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Choroideremia Treatment Market Size Estimates and Forecasts
1.4.1 Global Choroideremia Treatment Revenue 2018-2029
1.4.2 Global Choroideremia Treatment Sales 2018-2029
1.4.3 Global Choroideremia Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CHOROIDEREMIA TREATMENT MARKET COMPETITION BY MANUFACTURERS
2.1 Global Choroideremia Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Choroideremia Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Choroideremia Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Choroideremia Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Choroideremia Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Choroideremia Treatment, Product Type & Application
2.7 Choroideremia Treatment Market Competitive Situation and Trends
2.7.1 Choroideremia Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Choroideremia Treatment Players Market Share by Revenue
2.7.3 Global Choroideremia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CHOROIDEREMIA TREATMENT RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Choroideremia Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Choroideremia Treatment Global Choroideremia Treatment Sales by Region: 2018-2029
3.2.1 Global Choroideremia Treatment Sales by Region: 2018-2023
3.2.2 Global Choroideremia Treatment Sales by Region: 2024-2029
3.3 Global Choroideremia Treatment Global Choroideremia Treatment Revenue by Region: 2018-2029
3.3.1 Global Choroideremia Treatment Revenue by Region: 2018-2023
3.3.2 Global Choroideremia Treatment Revenue by Region: 2024-2029
3.4 North America Choroideremia Treatment Market Facts & Figures by Country
3.4.1 North America Choroideremia Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Choroideremia Treatment Sales by Country (2018-2029)
3.4.3 North America Choroideremia Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Choroideremia Treatment Market Facts & Figures by Country
3.5.1 Europe Choroideremia Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Choroideremia Treatment Sales by Country (2018-2029)
3.5.3 Europe Choroideremia Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Choroideremia Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Choroideremia Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Choroideremia Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Choroideremia Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Choroideremia Treatment Market Facts & Figures by Country
3.7.1 Latin America Choroideremia Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Choroideremia Treatment Sales by Country (2018-2029)
3.7.3 Latin America Choroideremia Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Choroideremia Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Choroideremia Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Choroideremia Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Choroideremia Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Choroideremia Treatment Sales by Type (2018-2029)
4.1.1 Global Choroideremia Treatment Sales by Type (2018-2023)
4.1.2 Global Choroideremia Treatment Sales by Type (2024-2029)
4.1.3 Global Choroideremia Treatment Sales Market Share by Type (2018-2029)
4.2 Global Choroideremia Treatment Revenue by Type (2018-2029)
4.2.1 Global Choroideremia Treatment Revenue by Type (2018-2023)
4.2.2 Global Choroideremia Treatment Revenue by Type (2024-2029)
4.2.3 Global Choroideremia Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Choroideremia Treatment Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Choroideremia Treatment Sales by Application (2018-2029)
5.1.1 Global Choroideremia Treatment Sales by Application (2018-2023)
5.1.2 Global Choroideremia Treatment Sales by Application (2024-2029)
5.1.3 Global Choroideremia Treatment Sales Market Share by Application (2018-2029)
5.2 Global Choroideremia Treatment Revenue by Application (2018-2029)
5.2.1 Global Choroideremia Treatment Revenue by Application (2018-2023)
5.2.2 Global Choroideremia Treatment Revenue by Application (2024-2029)
5.2.3 Global Choroideremia Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Choroideremia Treatment Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novartis AG Choroideremia Treatment Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Spark Therapeutics
6.2.1 Spark Therapeutics Corporation Information
6.2.2 Spark Therapeutics Description and Business Overview
6.2.3 Spark Therapeutics Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Spark Therapeutics Choroideremia Treatment Product Portfolio
6.2.5 Spark Therapeutics Recent Developments/Updates
6.3 Bluebird Bio Inc.
6.3.1 Bluebird Bio Inc. Corporation Information
6.3.2 Bluebird Bio Inc. Description and Business Overview
6.3.3 Bluebird Bio Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bluebird Bio Inc. Choroideremia Treatment Product Portfolio
6.3.5 Bluebird Bio Inc. Recent Developments/Updates
6.4 Biogen
6.4.1 Biogen Corporation Information
6.4.2 Biogen Description and Business Overview
6.4.3 Biogen Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biogen Choroideremia Treatment Product Portfolio
6.4.5 Biogen Recent Developments/Updates
6.5 Copernicus Therapeutics, Inc.
6.5.1 Copernicus Therapeutics, Inc. Corporation Information
6.5.2 Copernicus Therapeutics, Inc. Description and Business Overview
6.5.3 Copernicus Therapeutics, Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Copernicus Therapeutics, Inc. Choroideremia Treatment Product Portfolio
6.5.5 Copernicus Therapeutics, Inc. Recent Developments/Updates
6.6 4D Molecular Therapeutics
6.6.1 4D Molecular Therapeutics Corporation Information
6.6.2 4D Molecular Therapeutics Description and Business Overview
6.6.3 4D Molecular Therapeutics Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 4D Molecular Therapeutics Choroideremia Treatment Product Portfolio
6.6.5 4D Molecular Therapeutics Recent Developments/Updates
6.7 Wize Pharma Inc.
6.6.1 Wize Pharma Inc. Corporation Information
6.6.2 Wize Pharma Inc. Description and Business Overview
6.6.3 Wize Pharma Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Wize Pharma Inc. Choroideremia Treatment Product Portfolio
6.7.5 Wize Pharma Inc. Recent Developments/Updates
6.8 Retina Implant AG
6.8.1 Retina Implant AG Corporation Information
6.8.2 Retina Implant AG Description and Business Overview
6.8.3 Retina Implant AG Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Retina Implant AG Choroideremia Treatment Product Portfolio
6.8.5 Retina Implant AG Recent Developments/Updates
6.9 Hoffmann-La Roche Ltd
6.9.1 Hoffmann-La Roche Ltd Corporation Information
6.9.2 Hoffmann-La Roche Ltd Description and Business Overview
6.9.3 Hoffmann-La Roche Ltd Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hoffmann-La Roche Ltd Choroideremia Treatment Product Portfolio
6.9.5 Hoffmann-La Roche Ltd Recent Developments/Updates
6.10 Pixium Vision
6.10.1 Pixium Vision Corporation Information
6.10.2 Pixium Vision Description and Business Overview
6.10.3 Pixium Vision Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pixium Vision Choroideremia Treatment Product Portfolio
6.10.5 Pixium Vision Recent Developments/Updates
6.11 Merck
6.11.1 Merck Corporation Information
6.11.2 Merck Choroideremia Treatment Description and Business Overview
6.11.3 Merck Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Merck Choroideremia Treatment Product Portfolio
6.11.5 Merck Recent Developments/Updates
6.12 Teva
6.12.1 Teva Corporation Information
6.12.2 Teva Choroideremia Treatment Description and Business Overview
6.12.3 Teva Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Teva Choroideremia Treatment Product Portfolio
6.12.5 Teva Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Choroideremia Treatment Industry Chain Analysis
7.2 Choroideremia Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Choroideremia Treatment Production Mode & Process
7.4 Choroideremia Treatment Sales and Marketing
7.4.1 Choroideremia Treatment Sales Channels
7.4.2 Choroideremia Treatment Distributors
7.5 Choroideremia Treatment Customers
8 CHOROIDEREMIA TREATMENT MARKET DYNAMICS
8.1 Choroideremia Treatment Industry Trends
8.2 Choroideremia Treatment Market Drivers
8.3 Choroideremia Treatment Market Challenges
8.4 Choroideremia Treatment Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Choroideremia Treatment
1.2 Choroideremia Treatment Segment by Type
1.2.1 Global Choroideremia Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Oral
1.2.3 Intravenous
1.3 Choroideremia Treatment Segment by Application
1.3.1 Global Choroideremia Treatment Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Choroideremia Treatment Market Size Estimates and Forecasts
1.4.1 Global Choroideremia Treatment Revenue 2018-2029
1.4.2 Global Choroideremia Treatment Sales 2018-2029
1.4.3 Global Choroideremia Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CHOROIDEREMIA TREATMENT MARKET COMPETITION BY MANUFACTURERS
2.1 Global Choroideremia Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Choroideremia Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Choroideremia Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Choroideremia Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Choroideremia Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Choroideremia Treatment, Product Type & Application
2.7 Choroideremia Treatment Market Competitive Situation and Trends
2.7.1 Choroideremia Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Choroideremia Treatment Players Market Share by Revenue
2.7.3 Global Choroideremia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CHOROIDEREMIA TREATMENT RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Choroideremia Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Choroideremia Treatment Global Choroideremia Treatment Sales by Region: 2018-2029
3.2.1 Global Choroideremia Treatment Sales by Region: 2018-2023
3.2.2 Global Choroideremia Treatment Sales by Region: 2024-2029
3.3 Global Choroideremia Treatment Global Choroideremia Treatment Revenue by Region: 2018-2029
3.3.1 Global Choroideremia Treatment Revenue by Region: 2018-2023
3.3.2 Global Choroideremia Treatment Revenue by Region: 2024-2029
3.4 North America Choroideremia Treatment Market Facts & Figures by Country
3.4.1 North America Choroideremia Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Choroideremia Treatment Sales by Country (2018-2029)
3.4.3 North America Choroideremia Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Choroideremia Treatment Market Facts & Figures by Country
3.5.1 Europe Choroideremia Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Choroideremia Treatment Sales by Country (2018-2029)
3.5.3 Europe Choroideremia Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Choroideremia Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Choroideremia Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Choroideremia Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Choroideremia Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Choroideremia Treatment Market Facts & Figures by Country
3.7.1 Latin America Choroideremia Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Choroideremia Treatment Sales by Country (2018-2029)
3.7.3 Latin America Choroideremia Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Choroideremia Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Choroideremia Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Choroideremia Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Choroideremia Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Choroideremia Treatment Sales by Type (2018-2029)
4.1.1 Global Choroideremia Treatment Sales by Type (2018-2023)
4.1.2 Global Choroideremia Treatment Sales by Type (2024-2029)
4.1.3 Global Choroideremia Treatment Sales Market Share by Type (2018-2029)
4.2 Global Choroideremia Treatment Revenue by Type (2018-2029)
4.2.1 Global Choroideremia Treatment Revenue by Type (2018-2023)
4.2.2 Global Choroideremia Treatment Revenue by Type (2024-2029)
4.2.3 Global Choroideremia Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Choroideremia Treatment Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Choroideremia Treatment Sales by Application (2018-2029)
5.1.1 Global Choroideremia Treatment Sales by Application (2018-2023)
5.1.2 Global Choroideremia Treatment Sales by Application (2024-2029)
5.1.3 Global Choroideremia Treatment Sales Market Share by Application (2018-2029)
5.2 Global Choroideremia Treatment Revenue by Application (2018-2029)
5.2.1 Global Choroideremia Treatment Revenue by Application (2018-2023)
5.2.2 Global Choroideremia Treatment Revenue by Application (2024-2029)
5.2.3 Global Choroideremia Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Choroideremia Treatment Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novartis AG Choroideremia Treatment Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Spark Therapeutics
6.2.1 Spark Therapeutics Corporation Information
6.2.2 Spark Therapeutics Description and Business Overview
6.2.3 Spark Therapeutics Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Spark Therapeutics Choroideremia Treatment Product Portfolio
6.2.5 Spark Therapeutics Recent Developments/Updates
6.3 Bluebird Bio Inc.
6.3.1 Bluebird Bio Inc. Corporation Information
6.3.2 Bluebird Bio Inc. Description and Business Overview
6.3.3 Bluebird Bio Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bluebird Bio Inc. Choroideremia Treatment Product Portfolio
6.3.5 Bluebird Bio Inc. Recent Developments/Updates
6.4 Biogen
6.4.1 Biogen Corporation Information
6.4.2 Biogen Description and Business Overview
6.4.3 Biogen Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biogen Choroideremia Treatment Product Portfolio
6.4.5 Biogen Recent Developments/Updates
6.5 Copernicus Therapeutics, Inc.
6.5.1 Copernicus Therapeutics, Inc. Corporation Information
6.5.2 Copernicus Therapeutics, Inc. Description and Business Overview
6.5.3 Copernicus Therapeutics, Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Copernicus Therapeutics, Inc. Choroideremia Treatment Product Portfolio
6.5.5 Copernicus Therapeutics, Inc. Recent Developments/Updates
6.6 4D Molecular Therapeutics
6.6.1 4D Molecular Therapeutics Corporation Information
6.6.2 4D Molecular Therapeutics Description and Business Overview
6.6.3 4D Molecular Therapeutics Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 4D Molecular Therapeutics Choroideremia Treatment Product Portfolio
6.6.5 4D Molecular Therapeutics Recent Developments/Updates
6.7 Wize Pharma Inc.
6.6.1 Wize Pharma Inc. Corporation Information
6.6.2 Wize Pharma Inc. Description and Business Overview
6.6.3 Wize Pharma Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Wize Pharma Inc. Choroideremia Treatment Product Portfolio
6.7.5 Wize Pharma Inc. Recent Developments/Updates
6.8 Retina Implant AG
6.8.1 Retina Implant AG Corporation Information
6.8.2 Retina Implant AG Description and Business Overview
6.8.3 Retina Implant AG Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Retina Implant AG Choroideremia Treatment Product Portfolio
6.8.5 Retina Implant AG Recent Developments/Updates
6.9 Hoffmann-La Roche Ltd
6.9.1 Hoffmann-La Roche Ltd Corporation Information
6.9.2 Hoffmann-La Roche Ltd Description and Business Overview
6.9.3 Hoffmann-La Roche Ltd Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hoffmann-La Roche Ltd Choroideremia Treatment Product Portfolio
6.9.5 Hoffmann-La Roche Ltd Recent Developments/Updates
6.10 Pixium Vision
6.10.1 Pixium Vision Corporation Information
6.10.2 Pixium Vision Description and Business Overview
6.10.3 Pixium Vision Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pixium Vision Choroideremia Treatment Product Portfolio
6.10.5 Pixium Vision Recent Developments/Updates
6.11 Merck
6.11.1 Merck Corporation Information
6.11.2 Merck Choroideremia Treatment Description and Business Overview
6.11.3 Merck Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Merck Choroideremia Treatment Product Portfolio
6.11.5 Merck Recent Developments/Updates
6.12 Teva
6.12.1 Teva Corporation Information
6.12.2 Teva Choroideremia Treatment Description and Business Overview
6.12.3 Teva Choroideremia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Teva Choroideremia Treatment Product Portfolio
6.12.5 Teva Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Choroideremia Treatment Industry Chain Analysis
7.2 Choroideremia Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Choroideremia Treatment Production Mode & Process
7.4 Choroideremia Treatment Sales and Marketing
7.4.1 Choroideremia Treatment Sales Channels
7.4.2 Choroideremia Treatment Distributors
7.5 Choroideremia Treatment Customers
8 CHOROIDEREMIA TREATMENT MARKET DYNAMICS
8.1 Choroideremia Treatment Industry Trends
8.2 Choroideremia Treatment Market Drivers
8.3 Choroideremia Treatment Market Challenges
8.4 Choroideremia Treatment Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Choroideremia Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Choroideremia Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Choroideremia Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global Choroideremia Treatment Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Choroideremia Treatment Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Choroideremia Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Choroideremia Treatment Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Choroideremia Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Choroideremia Treatment, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Choroideremia Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Choroideremia Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Choroideremia Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Choroideremia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroideremia Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Choroideremia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Choroideremia Treatment Sales by Region (2018-2023) & (K Units)
Table 18. Global Choroideremia Treatment Sales Market Share by Region (2018-2023)
Table 19. Global Choroideremia Treatment Sales by Region (2024-2029) & (K Units)
Table 20. Global Choroideremia Treatment Sales Market Share by Region (2024-2029)
Table 21. Global Choroideremia Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Choroideremia Treatment Revenue Market Share by Region (2018-2023)
Table 23. Global Choroideremia Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Choroideremia Treatment Revenue Market Share by Region (2024-2029)
Table 25. North America Choroideremia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Choroideremia Treatment Sales by Country (2018-2023) & (K Units)
Table 27. North America Choroideremia Treatment Sales by Country (2024-2029) & (K Units)
Table 28. North America Choroideremia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Choroideremia Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Choroideremia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Choroideremia Treatment Sales by Country (2018-2023) & (K Units)
Table 32. Europe Choroideremia Treatment Sales by Country (2024-2029) & (K Units)
Table 33. Europe Choroideremia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Choroideremia Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Choroideremia Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Choroideremia Treatment Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Choroideremia Treatment Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Choroideremia Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Choroideremia Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Choroideremia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Choroideremia Treatment Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Choroideremia Treatment Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Choroideremia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Choroideremia Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Choroideremia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Choroideremia Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Choroideremia Treatment Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Choroideremia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Choroideremia Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Choroideremia Treatment Sales (K Units) by Type (2018-2023)
Table 51. Global Choroideremia Treatment Sales (K Units) by Type (2024-2029)
Table 52. Global Choroideremia Treatment Sales Market Share by Type (2018-2023)
Table 53. Global Choroideremia Treatment Sales Market Share by Type (2024-2029)
Table 54. Global Choroideremia Treatment Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Choroideremia Treatment Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Choroideremia Treatment Revenue Market Share by Type (2018-2023)
Table 57. Global Choroideremia Treatment Revenue Market Share by Type (2024-2029)
Table 58. Global Choroideremia Treatment Price (US$/Unit) by Type (2018-2023)
Table 59. Global Choroideremia Treatment Price (US$/Unit) by Type (2024-2029)
Table 60. Global Choroideremia Treatment Sales (K Units) by Application (2018-2023)
Table 61. Global Choroideremia Treatment Sales (K Units) by Application (2024-2029)
Table 62. Global Choroideremia Treatment Sales Market Share by Application (2018-2023)
Table 63. Global Choroideremia Treatment Sales Market Share by Application (2024-2029)
Table 64. Global Choroideremia Treatment Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Choroideremia Treatment Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Choroideremia Treatment Revenue Market Share by Application (2018-2023)
Table 67. Global Choroideremia Treatment Revenue Market Share by Application (2024-2029)
Table 68. Global Choroideremia Treatment Price (US$/Unit) by Application (2018-2023)
Table 69. Global Choroideremia Treatment Price (US$/Unit) by Application (2024-2029)
Table 70. Novartis AG Corporation Information
Table 71. Novartis AG Description and Business Overview
Table 72. Novartis AG Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Novartis AG Choroideremia Treatment Product
Table 74. Novartis AG Recent Developments/Updates
Table 75. Spark Therapeutics Corporation Information
Table 76. Spark Therapeutics Description and Business Overview
Table 77. Spark Therapeutics Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Spark Therapeutics Choroideremia Treatment Product
Table 79. Spark Therapeutics Recent Developments/Updates
Table 80. Bluebird Bio Inc. Corporation Information
Table 81. Bluebird Bio Inc. Description and Business Overview
Table 82. Bluebird Bio Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Bluebird Bio Inc. Choroideremia Treatment Product
Table 84. Bluebird Bio Inc. Recent Developments/Updates
Table 85. Biogen Corporation Information
Table 86. Biogen Description and Business Overview
Table 87. Biogen Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Biogen Choroideremia Treatment Product
Table 89. Biogen Recent Developments/Updates
Table 90. Copernicus Therapeutics, Inc. Corporation Information
Table 91. Copernicus Therapeutics, Inc. Description and Business Overview
Table 92. Copernicus Therapeutics, Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Copernicus Therapeutics, Inc. Choroideremia Treatment Product
Table 94. Copernicus Therapeutics, Inc. Recent Developments/Updates
Table 95. 4D Molecular Therapeutics Corporation Information
Table 96. 4D Molecular Therapeutics Description and Business Overview
Table 97. 4D Molecular Therapeutics Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. 4D Molecular Therapeutics Choroideremia Treatment Product
Table 99. 4D Molecular Therapeutics Recent Developments/Updates
Table 100. Wize Pharma Inc. Corporation Information
Table 101. Wize Pharma Inc. Description and Business Overview
Table 102. Wize Pharma Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Wize Pharma Inc. Choroideremia Treatment Product
Table 104. Wize Pharma Inc. Recent Developments/Updates
Table 105. Retina Implant AG Corporation Information
Table 106. Retina Implant AG Description and Business Overview
Table 107. Retina Implant AG Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Retina Implant AG Choroideremia Treatment Product
Table 109. Retina Implant AG Recent Developments/Updates
Table 110. Hoffmann-La Roche Ltd Corporation Information
Table 111. Hoffmann-La Roche Ltd Description and Business Overview
Table 112. Hoffmann-La Roche Ltd Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Hoffmann-La Roche Ltd Choroideremia Treatment Product
Table 114. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 115. Pixium Vision Corporation Information
Table 116. Pixium Vision Description and Business Overview
Table 117. Pixium Vision Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Pixium Vision Choroideremia Treatment Product
Table 119. Pixium Vision Recent Developments/Updates
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Merck Choroideremia Treatment Product
Table 124. Merck Recent Developments/Updates
Table 125. Teva Corporation Information
Table 126. Teva Description and Business Overview
Table 127. Teva Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Teva Choroideremia Treatment Product
Table 129. Teva Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Choroideremia Treatment Distributors List
Table 133. Choroideremia Treatment Customers List
Table 134. Choroideremia Treatment Market Trends
Table 135. Choroideremia Treatment Market Drivers
Table 136. Choroideremia Treatment Market Challenges
Table 137. Choroideremia Treatment Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 1. Global Choroideremia Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Choroideremia Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Choroideremia Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global Choroideremia Treatment Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Choroideremia Treatment Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Choroideremia Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Choroideremia Treatment Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Choroideremia Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Choroideremia Treatment, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Choroideremia Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Choroideremia Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Choroideremia Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Choroideremia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroideremia Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Choroideremia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Choroideremia Treatment Sales by Region (2018-2023) & (K Units)
Table 18. Global Choroideremia Treatment Sales Market Share by Region (2018-2023)
Table 19. Global Choroideremia Treatment Sales by Region (2024-2029) & (K Units)
Table 20. Global Choroideremia Treatment Sales Market Share by Region (2024-2029)
Table 21. Global Choroideremia Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Choroideremia Treatment Revenue Market Share by Region (2018-2023)
Table 23. Global Choroideremia Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Choroideremia Treatment Revenue Market Share by Region (2024-2029)
Table 25. North America Choroideremia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Choroideremia Treatment Sales by Country (2018-2023) & (K Units)
Table 27. North America Choroideremia Treatment Sales by Country (2024-2029) & (K Units)
Table 28. North America Choroideremia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Choroideremia Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Choroideremia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Choroideremia Treatment Sales by Country (2018-2023) & (K Units)
Table 32. Europe Choroideremia Treatment Sales by Country (2024-2029) & (K Units)
Table 33. Europe Choroideremia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Choroideremia Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Choroideremia Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Choroideremia Treatment Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Choroideremia Treatment Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Choroideremia Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Choroideremia Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Choroideremia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Choroideremia Treatment Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Choroideremia Treatment Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Choroideremia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Choroideremia Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Choroideremia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Choroideremia Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Choroideremia Treatment Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Choroideremia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Choroideremia Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Choroideremia Treatment Sales (K Units) by Type (2018-2023)
Table 51. Global Choroideremia Treatment Sales (K Units) by Type (2024-2029)
Table 52. Global Choroideremia Treatment Sales Market Share by Type (2018-2023)
Table 53. Global Choroideremia Treatment Sales Market Share by Type (2024-2029)
Table 54. Global Choroideremia Treatment Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Choroideremia Treatment Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Choroideremia Treatment Revenue Market Share by Type (2018-2023)
Table 57. Global Choroideremia Treatment Revenue Market Share by Type (2024-2029)
Table 58. Global Choroideremia Treatment Price (US$/Unit) by Type (2018-2023)
Table 59. Global Choroideremia Treatment Price (US$/Unit) by Type (2024-2029)
Table 60. Global Choroideremia Treatment Sales (K Units) by Application (2018-2023)
Table 61. Global Choroideremia Treatment Sales (K Units) by Application (2024-2029)
Table 62. Global Choroideremia Treatment Sales Market Share by Application (2018-2023)
Table 63. Global Choroideremia Treatment Sales Market Share by Application (2024-2029)
Table 64. Global Choroideremia Treatment Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Choroideremia Treatment Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Choroideremia Treatment Revenue Market Share by Application (2018-2023)
Table 67. Global Choroideremia Treatment Revenue Market Share by Application (2024-2029)
Table 68. Global Choroideremia Treatment Price (US$/Unit) by Application (2018-2023)
Table 69. Global Choroideremia Treatment Price (US$/Unit) by Application (2024-2029)
Table 70. Novartis AG Corporation Information
Table 71. Novartis AG Description and Business Overview
Table 72. Novartis AG Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Novartis AG Choroideremia Treatment Product
Table 74. Novartis AG Recent Developments/Updates
Table 75. Spark Therapeutics Corporation Information
Table 76. Spark Therapeutics Description and Business Overview
Table 77. Spark Therapeutics Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Spark Therapeutics Choroideremia Treatment Product
Table 79. Spark Therapeutics Recent Developments/Updates
Table 80. Bluebird Bio Inc. Corporation Information
Table 81. Bluebird Bio Inc. Description and Business Overview
Table 82. Bluebird Bio Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Bluebird Bio Inc. Choroideremia Treatment Product
Table 84. Bluebird Bio Inc. Recent Developments/Updates
Table 85. Biogen Corporation Information
Table 86. Biogen Description and Business Overview
Table 87. Biogen Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Biogen Choroideremia Treatment Product
Table 89. Biogen Recent Developments/Updates
Table 90. Copernicus Therapeutics, Inc. Corporation Information
Table 91. Copernicus Therapeutics, Inc. Description and Business Overview
Table 92. Copernicus Therapeutics, Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Copernicus Therapeutics, Inc. Choroideremia Treatment Product
Table 94. Copernicus Therapeutics, Inc. Recent Developments/Updates
Table 95. 4D Molecular Therapeutics Corporation Information
Table 96. 4D Molecular Therapeutics Description and Business Overview
Table 97. 4D Molecular Therapeutics Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. 4D Molecular Therapeutics Choroideremia Treatment Product
Table 99. 4D Molecular Therapeutics Recent Developments/Updates
Table 100. Wize Pharma Inc. Corporation Information
Table 101. Wize Pharma Inc. Description and Business Overview
Table 102. Wize Pharma Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Wize Pharma Inc. Choroideremia Treatment Product
Table 104. Wize Pharma Inc. Recent Developments/Updates
Table 105. Retina Implant AG Corporation Information
Table 106. Retina Implant AG Description and Business Overview
Table 107. Retina Implant AG Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Retina Implant AG Choroideremia Treatment Product
Table 109. Retina Implant AG Recent Developments/Updates
Table 110. Hoffmann-La Roche Ltd Corporation Information
Table 111. Hoffmann-La Roche Ltd Description and Business Overview
Table 112. Hoffmann-La Roche Ltd Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Hoffmann-La Roche Ltd Choroideremia Treatment Product
Table 114. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 115. Pixium Vision Corporation Information
Table 116. Pixium Vision Description and Business Overview
Table 117. Pixium Vision Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Pixium Vision Choroideremia Treatment Product
Table 119. Pixium Vision Recent Developments/Updates
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Merck Choroideremia Treatment Product
Table 124. Merck Recent Developments/Updates
Table 125. Teva Corporation Information
Table 126. Teva Description and Business Overview
Table 127. Teva Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Teva Choroideremia Treatment Product
Table 129. Teva Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Choroideremia Treatment Distributors List
Table 133. Choroideremia Treatment Customers List
Table 134. Choroideremia Treatment Market Trends
Table 135. Choroideremia Treatment Market Drivers
Table 136. Choroideremia Treatment Market Challenges
Table 137. Choroideremia Treatment Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Choroideremia Treatment
Figure 2. Global Choroideremia Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Choroideremia Treatment Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Intravenous Product Picture
Figure 6. Global Choroideremia Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Choroideremia Treatment Market Share by Application in 2022 & 2029
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Global Choroideremia Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Choroideremia Treatment Market Size (2018-2029) & (US$ Million)
Figure 13. Global Choroideremia Treatment Sales (2018-2029) & (K Units)
Figure 14. Global Choroideremia Treatment Average Price (US$/Unit) & (2018-2029)
Figure 15. Choroideremia Treatment Report Years Considered
Figure 16. Choroideremia Treatment Sales Share by Manufacturers in 2022
Figure 17. Global Choroideremia Treatment Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Choroideremia Treatment Players: Market Share by Revenue in 2022
Figure 19. Choroideremia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Choroideremia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Choroideremia Treatment Sales Market Share by Country (2018-2029)
Figure 22. North America Choroideremia Treatment Revenue Market Share by Country (2018-2029)
Figure 23. United States Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Choroideremia Treatment Sales Market Share by Country (2018-2029)
Figure 26. Europe Choroideremia Treatment Revenue Market Share by Country (2018-2029)
Figure 27. Germany Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Choroideremia Treatment Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Choroideremia Treatment Revenue Market Share by Region (2018-2029)
Figure 34. China Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Choroideremia Treatment Sales Market Share by Country (2018-2029)
Figure 42. Latin America Choroideremia Treatment Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Choroideremia Treatment Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Choroideremia Treatment Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Choroideremia Treatment by Type (2018-2029)
Figure 53. Global Revenue Market Share of Choroideremia Treatment by Type (2018-2029)
Figure 54. Global Choroideremia Treatment Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Choroideremia Treatment by Application (2018-2029)
Figure 56. Global Revenue Market Share of Choroideremia Treatment by Application (2018-2029)
Figure 57. Global Choroideremia Treatment Price (US$/Unit) by Application (2018-2029)
Figure 58. Choroideremia Treatment Value Chain
Figure 59. Choroideremia Treatment Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Product Picture of Choroideremia Treatment
Figure 2. Global Choroideremia Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Choroideremia Treatment Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Intravenous Product Picture
Figure 6. Global Choroideremia Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Choroideremia Treatment Market Share by Application in 2022 & 2029
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Global Choroideremia Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Choroideremia Treatment Market Size (2018-2029) & (US$ Million)
Figure 13. Global Choroideremia Treatment Sales (2018-2029) & (K Units)
Figure 14. Global Choroideremia Treatment Average Price (US$/Unit) & (2018-2029)
Figure 15. Choroideremia Treatment Report Years Considered
Figure 16. Choroideremia Treatment Sales Share by Manufacturers in 2022
Figure 17. Global Choroideremia Treatment Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Choroideremia Treatment Players: Market Share by Revenue in 2022
Figure 19. Choroideremia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Choroideremia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Choroideremia Treatment Sales Market Share by Country (2018-2029)
Figure 22. North America Choroideremia Treatment Revenue Market Share by Country (2018-2029)
Figure 23. United States Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Choroideremia Treatment Sales Market Share by Country (2018-2029)
Figure 26. Europe Choroideremia Treatment Revenue Market Share by Country (2018-2029)
Figure 27. Germany Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Choroideremia Treatment Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Choroideremia Treatment Revenue Market Share by Region (2018-2029)
Figure 34. China Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Choroideremia Treatment Sales Market Share by Country (2018-2029)
Figure 42. Latin America Choroideremia Treatment Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Choroideremia Treatment Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Choroideremia Treatment Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Choroideremia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Choroideremia Treatment by Type (2018-2029)
Figure 53. Global Revenue Market Share of Choroideremia Treatment by Type (2018-2029)
Figure 54. Global Choroideremia Treatment Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Choroideremia Treatment by Application (2018-2029)
Figure 56. Global Revenue Market Share of Choroideremia Treatment by Application (2018-2029)
Figure 57. Global Choroideremia Treatment Price (US$/Unit) by Application (2018-2029)
Figure 58. Choroideremia Treatment Value Chain
Figure 59. Choroideremia Treatment Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
